New Legend Ph1 Trial for CD4 CAR-T (LB1901) in R/R T-Cell Lymphoma Posted
Here is a brief preview of this blast: On Friday, January 15, a new Legend-sponsored Ph1 trial was observed on CT.gov for a first-in-human study of LB1901 (CD4 CAR-T) in ≥3L r/r T cell Lymphoma (TCL). Below, Celltelligence provides details for this trial and how LB1901 compares to Autolus’s AUTO4 program.